Torrent Pharmaceuticals Limited again extended its recall of blood pressure medications due to concerns that the tablets contained small amounts of cancer-causing ingredients.
In a statement on September 19, the Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional batches of its Losartan Potassium USP tablets and Losartan Potassium / hydrochlorothiazide tablets used to treat hypertension , patients with left ventricular hypertrophy and nephropathy in patients with type 2 diabetes.
BLOOD PRESSURE MEDICINAL USE OF ADVANCED POSSIBLE CONDITIONS OF CANCER
lotto tablets Losartan Potassium USP and 2 batches of tablets Losartan Potassium / Hydrochlorothiazide, USP, ”says the FDA in a statement [
The ingredient found in the tablets was identified as N-methylnitrosobutyric acid (NMBA), a known animal and a potential human carcinogen. The company said the withdrawal only affected products found to contain more than the FDA NMBA.
'Patients taking Losartan tablets with potassium, USP and Losartan tablets with potassium / hydrochlorothiazide, USP should continue to take their medicines as the risk of harm to the patient's health may be higher if the treatment is stopped immediately without alternative treatment, "the FDA says, advising patients to contact their pharmacist or doctor about an alternative medicine.
News marks the fifth time the company has expanded its recall. The fourth was announced in April.
Click here to get the application of FOX NEWS
For more information on newly downloaded batches, read the announcement from the pharmaceutical company FDA.gov.
Fox News Alexandria Hein contributed to this report.